Literature DB >> 19842564

Hypervascular liver lesions.

Aya Kamaya1, Katherine E Maturen, Grace A Tye, Yueyi I Liu, Naveen N Parti, Terry S Desser.   

Abstract

Hypervascular hepatocellular lesions include both benign and malignant etiologies. In the benign category, focal nodular hyperplasia and adenoma are typically hypervascular. In addition, some regenerative nodules in cirrhosis may be hypervascular. Malignant hypervascular primary hepatocellular lesions include hepatocellular carcinoma, fibrolamellar carcinoma, and peripheral cholangiocarcinoma. Vascular liver lesions often appear hypervascular because they tend to follow the enhancement of the blood pool; these include hemangiomas, arteriovenous malformations, angiosarcomas, and peliosis. While most gastrointestinal malignancies that metastasize to the liver will appear hypovascular on arterial and portal-venous phase imaging, certain cancers such as metastatic neuroendocrine tumors (including pancreatic neuroendocrine tumors, carcinoid, and gastrointestinal stromal tumors) tend to produce hypervascular metastases due to the greater recruitment of arterial blood supply. Finally, rare hepatic lesions such as glomus tumor and inflammatory pseudotumor may have a hypervascular appearance.

Entities:  

Mesh:

Year:  2009        PMID: 19842564     DOI: 10.1053/j.sult.2009.06.001

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  10 in total

1.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

2.  Insulinoma with focal hepatic lesions: malignant insulinoma?

Authors:  Hichem Jerraya; Yossra Zidi-Mouaffek; Safi Dokmak; Chadli Dziri
Journal:  BMJ Case Rep       Date:  2015-12-15

Review 3.  That liver lesion on MDCT in the oncology patient: is it important?

Authors:  Richard M Gore; Kiran H Thakrar; Daniel R Wenzke; Geraldine M Newmark; Uday K Mehta; Jonathan W Berlin
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

Review 4.  Consensus report of the 4th International Forum for Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid Magnetic Resonance Imaging.

Authors:  Jeong Min Lee; Christoph J Zech; Luigi Bolondi; Eduard Jonas; Myeong-Jin Kim; Osamu Matsui; Elmar M Merkle; Michiie Sakamoto; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2011-07-22       Impact factor: 3.500

5.  Clinical value of LHPP-associated microRNAs combined with protein induced by vitamin K deficiency or antagonist-II in the diagnosis of alpha-fetoprotein-negative hepatocellular carcinoma.

Authors:  Zeyu Tian; Tanbo Yu; Hongyan Wei; Ning Ning
Journal:  J Clin Lab Anal       Date:  2019-11-06       Impact factor: 2.352

6.  Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging.

Authors:  Vijayanadh Ojili; Sree Harsha Tirumani; Kedar N Chintapalli; Gowthaman Gunabushanam
Journal:  J Clin Imaging Sci       Date:  2013-01-30

Review 7.  The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.

Authors:  Andor F van den Hoven; Maarten L J Smits; Charlotte E N M Rosenbaum; Helena M Verkooijen; Maurice A A J van den Bosch; Marnix G E H Lam
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

8.  Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.

Authors:  Consolato M Sergi
Journal:  Diagnostics (Basel)       Date:  2015-12-30

9.  A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.

Authors:  Pei Nie; Guangjie Yang; Jian Guo; Jingjing Chen; Xiaoli Li; Qinglian Ji; Jie Wu; Jingjing Cui; Wenjian Xu
Journal:  Cancer Imaging       Date:  2020-02-24       Impact factor: 3.909

Review 10.  Imaging evaluation of the liver in oncology patients: A comparison of techniques.

Authors:  Patrícia S Freitas; Catarina Janicas; José Veiga; António P Matos; Vasco Herédia; Miguel Ramalho
Journal:  World J Hepatol       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.